-
Question 1
Incorrect
-
What is the recommended next step in managing the blood pressure of a 42 year old woman with a history of depression and a recent paracetamol overdose who has a manual blood pressure reading of 165/85 mmHg?
Your Answer: Screen for causes of secondary hypertension
Correct Answer: Offer ambulatory blood pressure monitoring
Explanation:The National Institute for Clinical Excellence updated its guideline for hypertension management in 2011, placing emphasis on the use of ambulatory blood pressure monitoring (ABPM) to confirm hypertension in individuals with elevated clinic readings. ABPM involves taking two measurements per hour during waking hours and using the average of at least 14 measurements to confirm a diagnosis of hypertension. Secondary causes of hypertension should be investigated in patients under 40 without traditional risk factors, those with other symptoms of secondary causes, and those with resistant hypertension. Hyperaldosteronism is the most common cause of secondary hypertension, and a trial of spironolactone may be used for both therapeutic and diagnostic purposes. Drug treatment for essential hypertension involves ACE inhibitors for those under 55 and calcium channel blockers for those over 55 or of black African or Caribbean origin. Step 2 involves using both ACE inhibitors and calcium channel blockers, while step 3 adds a thiazide-like diuretic. Further diuretics, beta-blockers, or alpha blockers may be considered in step 4, with expert advice sought. For a more detailed explanation, refer to the provided link.
NICE released updated guidelines in 2019 for the management of hypertension, building on previous guidelines from 2011. These guidelines aimed to classify hypertension into stages and recommend the use of ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) to accurately diagnose hypertension. This is important because some patients experience white coat hypertension, where their blood pressure rises in a clinical setting, leading to potential overdiagnosis of hypertension. ABPM and HBPM allow for a more accurate assessment of a patient’s overall blood pressure and can prevent overdiagnosis.
NICE recommends measuring blood pressure in both arms when considering a diagnosis of hypertension and repeating measurements if there is a difference of more than 20 mmHg between arms. If the blood pressure is >= 140/90 mmHg, NICE suggests offering ABPM or HBPM to confirm the diagnosis. If the blood pressure is >= 180/120 mmHg, referral for specialist assessment is recommended if there are signs of retinal haemorrhage or papilloedema or life-threatening symptoms. If target organ damage is identified, antihypertensive drug treatment may be started immediately.
ABPM involves taking at least 2 measurements per hour during the person’s usual waking hours and using the average value of at least 14 measurements. If ABPM is not tolerated, HBPM should be offered. HBPM involves taking two consecutive measurements at least 1 minute apart, twice daily for at least 4 days, and using the average value of all remaining measurements.
Interpreting the results of ABPM/HBPM is important for determining treatment. If the average blood pressure is >= 135/85 mmHg (stage 1 hypertension), treatment may be considered for patients under 80 years of age with target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. In 2019, NICE also recommended considering antihypertensive drug treatment for adults under 60 with stage 1 hypertension and an estimated 10-year risk below 10%. If the average blood pressure is >= 150/95 mmHg (stage 2 hypertension), drug treatment should be offered regardless of age.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 2
Correct
-
A 72-year-old man visits his General Practitioner for his annual medication review. He has hypertension and gout and is currently taking allopurinol 300 mg, amlodipine 10 mg and atorvastatin 20 mg. His home blood pressure readings average at 150/88 mmHg. His recent blood tests of glycosylated haemoglobin (HbA1c), renal profile and lipids are normal. Which of the following medications would be the most appropriate to add to his current regime?
Your Answer: Ramipril
Explanation:The patient’s hypertension is not well controlled despite being on the maximum dose of a calcium-channel blocker. According to NICE guidance, the next step in treatment should be a thiazide-like diuretic or an ACE inhibitor. However, as the patient has a history of recurrent gout, a diuretic is not advisable, and an ACE inhibitor such as ramipril is the most appropriate choice.
Aspirin 75 mg was previously recommended for primary prevention of cardiovascular disease in patients with multiple risk factors. However, current advice is to only consider prescribing aspirin after a careful risk assessment in patients with a high risk of stroke or myocardial infarction. Routine prescribing of antiplatelets for primary prevention is no longer recommended due to the risk of gastrointestinal bleed outweighing the benefits.
NICE no longer recommends initiating thiazide diuretics for hypertension treatment. Patients already established on this medication and whose BP is well controlled should continue. However, thiazide-like diuretics or ACE inhibitors are preferred as second-line treatment for hypertension in patients already on a calcium-channel blocker.
Diltiazem and amlodipine are both calcium-channel blockers, and medication from a different class of antihypertensives should be added.
Indapamide is a thiazide-like diuretic recommended as a second-line treatment for hypertension not controlled on the maximum dose of a calcium-channel blocker. However, as the patient has a history of recurrent gout, which can be exacerbated by thiazide and thiazide-like diuretics, an ACE inhibitor would be a more suitable choice.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 3
Incorrect
-
A 63-year-old man presents to the emergency department with sudden-onset chest pain and nausea. He is not taking any regular medications. An ECG reveals ST depression and T wave inversion in leads V2-V4, and troponin levels are elevated. The patient receives a STAT 300mg aspirin, and there are no immediate plans for primary PCI. According to the GRACE score, the 6-month mortality risk is 8.0%. The patient is stable. What is the best course of treatment going forward?
Your Answer: Fondaparinux, clopidogrel, and refer for coronary angiography in 3 months
Correct Answer: Fondaparinux, prasugrel or ticagrelor, and refer for coronary angiography within 72 hours
Explanation:The current treatment plan of prescribing fondaparinux, clopidogrel, and scheduling a coronary angiography in 3 months is incorrect. Clopidogrel is typically prescribed for patients with a higher risk of bleeding or those taking an oral anticoagulant. Additionally, delaying definitive treatment for a high-risk patient by scheduling a coronary angiography in 3 months could lead to increased mortality. Instead, a more appropriate treatment plan would involve prescribing prasugrel, unfractionated heparin, and a glycoprotein IIB/IIIA inhibitor, and referring the patient for urgent PCI within 2 hours. However, it should be noted that this treatment plan is specific to patients with STEMI and access to PCI facilities.
Managing Acute Coronary Syndrome: A Summary of NICE Guidelines
Acute coronary syndrome (ACS) is a common and serious medical condition that requires prompt management. The management of ACS has evolved over the years, with the development of new drugs and procedures such as percutaneous coronary intervention (PCI). The National Institute for Health and Care Excellence (NICE) has updated its guidelines on the management of ACS in 2020.
ACS can be classified into three subtypes: ST-elevation myocardial infarction (STEMI), non ST-elevation myocardial infarction (NSTEMI), and unstable angina. The management of ACS depends on the subtype. However, there are common initial drug therapies for all patients with ACS, such as aspirin and nitrates. Oxygen should only be given if the patient has oxygen saturations below 94%, and morphine should only be given for severe pain.
For patients with STEMI, the first step is to assess eligibility for coronary reperfusion therapy, which can be either PCI or fibrinolysis. Patients with NSTEMI/unstable angina require a risk assessment using the Global Registry of Acute Coronary Events (GRACE) tool to determine whether they need coronary angiography (with follow-on PCI if necessary) or conservative management.
This summary provides an overview of the NICE guidelines for managing ACS. The guidelines are complex and depend on individual patient factors, so healthcare professionals should review the full guidelines for further details. Proper management of ACS can improve patient outcomes and reduce the risk of complications.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 4
Correct
-
A 55-year-old man with no significant medical history presents to the hospital with severe chest pain. Upon arrival, an ECG reveals anterior ST elevation, and he is promptly treated with thrombolysis, resulting in the resolution of symptoms and ECG changes. What combination of medications should he be prescribed four weeks after the event?
Your Answer: ACE inhibitor + beta-blocker + statin + aspirin + clopidogrel
Explanation:Myocardial infarction (MI) is a serious condition that requires proper management to prevent further complications. In 2013, NICE released guidelines on the secondary prevention of MI. One of the key recommendations is the use of four drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent), ACE inhibitor, beta-blocker, and statin. Patients are also advised to adopt a Mediterranean-style diet and engage in regular exercise. Sexual activity may resume four weeks after an uncomplicated MI, and PDE5 inhibitors may be used six months after the event.
Most patients with acute coronary syndrome are now given dual antiplatelet therapy, with ticagrelor and prasugrel being the preferred options. The treatment period for these drugs is 12 months, after which they should be stopped. However, this period may be adjusted for patients at high risk of bleeding or further ischaemic events. Additionally, patients with heart failure and left ventricular systolic dysfunction should be treated with an aldosterone antagonist within 3-14 days of the MI, preferably after ACE inhibitor therapy.
Overall, the NICE guidelines provide a comprehensive approach to the secondary prevention of MI. By following these recommendations, patients can reduce their risk of further complications and improve their overall health outcomes.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 5
Correct
-
A 55-year-old man with NYHA class III heart failure is currently on furosemide and ramipril. Which beta-blocker would be the most appropriate to add for improving his long-term prognosis?
Your Answer: Bisoprolol
Explanation:The use of carvedilol and bisoprolol has been proven to decrease mortality in stable heart failure patients, while there is no evidence to support the use of other beta-blockers.
Drug Management for Chronic Heart Failure: NICE Guidelines
Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.
Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 6
Incorrect
-
A 55-year-old man presents to the Emergency Department with a 2-day history of malaise, fever and night sweats. He also complains that he has recently developed increased sensitivity in his fingertips and states that every time he touches something his fingers hurt.
His past medical history includes diabetes and end-stage chronic kidney disease, for which he receives regular haemodialysis. His parameters include a blood pressure of 130/95 mmHg, oxygen saturation of 98%, heart rate 120 bpm and a temperature of 38.2°C.
Which of the following investigations would be needed to make a diagnosis?
Select the SINGLE best investigation from the list below.
Select ONE option only.Your Answer: Sputum culture
Correct Answer: Echocardiogram
Explanation:Diagnostic Tests for a Patient with Suspected Infective Endocarditis
Suspected infective endocarditis (IE) requires a thorough diagnostic workup to confirm the diagnosis and rule out other potential conditions. One of the major symptoms of IE is the development of Osler nodes, which are tender lumps found on the fingers and toes. Here are some diagnostic tests that may be used to evaluate a patient with suspected IE:
Echocardiogram
An echocardiogram is a crucial diagnostic test for IE. It is used to detect any abnormalities in the heart valves or chambers that may indicate the presence of IE. The modified Duke’s criteria, which are used to diagnose IE, include echocardiography as one of the major criteria.
Nerve Conduction Studies
Nerve conduction studies are used to detect any damage to the peripheral nerves. While this test may be used to evaluate conditions such as carpal tunnel syndrome or sciatica, it is not typically used to diagnose IE. In this case, the painful sensation in the fingertips is more likely due to Osler nodes than an underlying neurological disorder.
Chest X-ray
A chest X-ray is not typically indicated in a patient with suspected IE. While pneumonia may present with symptoms similar to those of IE, such as fever and malaise, other symptoms such as coughing and sputum production are more indicative of pneumonia.
Mantoux Test
The Mantoux test is used to detect latent tuberculosis (TB). While TB may present with symptoms similar to those of IE, such as night sweats and fever, a Mantoux test is not typically used to diagnose IE. In this case, the lack of risk factors for TB and the presence of Osler nodes suggest a diagnosis of IE.
Sputum Culture
A sputum culture may be used to diagnose respiratory conditions such as pneumonia. However, in a patient without a cough, a sputum culture is less likely to confirm a diagnosis. Other symptoms such as coughing and sputum production are more indicative of pneumonia.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 7
Correct
-
Left bundle branch block is associated with which one of the following conditions?
Your Answer: Ischaemic heart disease
Explanation:ECG Findings in Various Cardiovascular Conditions
New-onset left bundle branch block may indicate ischaemic heart disease and could be a sign of STEMI if the patient’s symptoms match the diagnosis. Pericarditis typically causes widespread ST elevation on an ECG. Mitral stenosis can lead to left atrial enlargement and potentially atrial fibrillation. Pulmonary embolism often results in a right bundle branch block or a right ventricular strain pattern of S1Q3T3. Tricuspid stenosis can also cause right ventricular strain. It’s worth noting that mitral stenosis, tricuspid stenosis, and secondary pulmonary hypertension due to PE are associated with right ventricular strain and hypertrophy with partial or complete right bundle branch block, while pericarditis is not typically associated with bundle branch block.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 8
Incorrect
-
A 55 year old woman presents to the Emergency Department complaining of a cough with green sputum and palpitations. She reports feeling very sick, feverish, and tired. Upon examination, she exhibits bronchial breathing at her right base, with a respiratory rate of 25 breaths per minute and oxygen saturation of 95% on room air. Her heart sounds are normal, but her heartbeat is irregularly irregular, with a heart rate of 120 beats per minute and blood pressure of 90/40 mmHg. An ECG reveals atrial fibrillation with a fast ventricular rate. The patient has no prior history of atrial fibrillation. What is the initial treatment that should be administered?
Your Answer: Digoxin
Correct Answer: Intravenous fluids
Explanation:Patient is septic from pneumonia and has developed atrial fibrillation. Treatment should focus on resolving the sepsis with IV fluids and antibiotics, which may also resolve the AF. If AF persists, other treatment options may be considered.
Understanding Sepsis: Classification and Management
Sepsis is a life-threatening condition caused by a dysregulated host response to an infection. In recent years, the classification of sepsis has changed, with the old category of severe sepsis no longer in use. Instead, the Surviving Sepsis Guidelines now recognize sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, and septic shock as a more severe form of sepsis. The term ‘systemic inflammatory response syndrome (SIRS)’ has also fallen out of favor.
To manage sepsis, it is important to identify and treat the underlying cause of the infection and support the patient regardless of the cause or severity. However, if any red flags are present, the ‘sepsis six’ should be started immediately. This includes administering oxygen, taking blood cultures, giving broad-spectrum antibiotics, giving intravenous fluid challenges, measuring serum lactate, and measuring accurate hourly urine output.
NICE released its own guidelines in 2016, which focus on the risk stratification and management of patients with suspected sepsis. For risk stratification, NICE recommends using red flag and amber flag criteria. If any red flags are present, the sepsis six should be started immediately. If any amber flags are present, the patient should be closely monitored and managed accordingly.
To help identify and categorize patients, the Sequential (Sepsis-Related) Organ Failure Assessment Score (SOFA) is increasingly used. The score grades abnormality by organ system and accounts for clinical interventions. A SOFA score of 2 or more reflects an overall mortality risk of approximately 10% in a general hospital population with suspected infection. Even patients presenting with modest dysfunction can deteriorate further, emphasizing the seriousness of this condition and the need for prompt and appropriate intervention.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 9
Incorrect
-
A 28-year-old man visits his General Practitioner, requesting a health check. While he feels very well, he is concerned, as his father had a myocardial infarction (MI) at the age of 43.
On examination, his blood pressure and pulse are normal. His body mass index (BMI) is also within the normal range. There is a white/grey opacity surrounding the periphery of his cornea in both eyes.
What is the most appropriate investigation for this patient?Your Answer: Renal profile
Correct Answer: Lipid profile
Explanation:Appropriate Laboratory Tests for Cardiovascular Health Check
To assess a patient’s cardiovascular health, various laboratory tests may be conducted. However, the choice of tests should be based on the patient’s symptoms, medical history, and physical examination. In the case of a patient with signs of hyperlipidaemia, a lipid profile would be the most appropriate test to diagnose familial hyperlipidaemia. On the other hand, an ECG would be indicated if there was a family history of sudden death to rule out underlying rhythm issues. A fasting glucose test would not be necessary in this case, but it may be conducted as part of a cardiovascular health check. A full blood count would not aid in the diagnosis of hyperlipidaemia, but it may be conducted if the patient was experiencing chest pain to exclude anaemia as a cause of his symptoms. Lastly, a renal profile would not aid in the diagnosis of familial hyperlipidaemia, but it may be conducted to rule out secondary causes if the patient were hypertensive.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 10
Correct
-
A 42-year-old woman presented with swelling in her feet and mentioned that she uses two pillows while sleeping. What is the most suitable initial investigation?
Your Answer: Plasma NT-proBNP
Explanation:Diagnostic Tests for Suspected Heart Failure
When a patient presents with symptoms of peripheral edema and orthopnea, heart failure is a likely diagnosis. To confirm this, NICE guidelines recommend using N-terminal pro-B-type natriuretic peptide (NT-proBNP) as an initial investigation. A level below 400 ng/litre makes heart failure unlikely, while levels between 400 and 2,000 ng/litre require referral for specialist assessment within 6 weeks. Levels above 2,000 ng/litre require referral within 2 weeks. An echocardiogram should be performed to quantify ventricular function if the ECG and NT-proBNP are abnormal. Blood cultures can also be useful for detecting systemic infection or endocarditis. An exercise tolerance test is more appropriate for suspected coronary artery disease. Finally, rheumatoid factor is a non-specific test for autoimmune conditions.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 11
Correct
-
A 55-year-old woman comes to the clinic after being released from the acute medical unit 14 days ago. She was admitted due to pleuritic chest pain and shortness of breath, and was diagnosed with a pulmonary embolism. Apixaban was started during her hospital stay. The patient has a clean medical history and is generally healthy. What is the appropriate duration of anticoagulation therapy for this individual?
Your Answer: 6 months
Explanation:Patients with ‘unprovoked’ pulmonary embolisms usually require anticoagulation treatment for a duration of 6 months, as there are no temporary risk factors for venous thromboembolism.
Management of Pulmonary Embolism: NICE Guidelines
Pulmonary embolism (PE) is a serious condition that requires prompt management. The National Institute for Health and Care Excellence (NICE) updated their guidelines on the management of venous thromboembolism (VTE) in 2020, with some key changes. One of the significant changes is the recommendation to use direct oral anticoagulants (DOACs) as the first-line treatment for most people with VTE, including those with active cancer. Another change is the increasing use of outpatient treatment for low-risk PE patients, determined by a validated risk stratification tool.
Anticoagulant therapy is the cornerstone of VTE management, and the guidelines recommend using apixaban or rivaroxaban as the first-line treatment following the diagnosis of a PE. If neither of these is suitable, LMWH followed by dabigatran or edoxaban or LMWH followed by a vitamin K antagonist (VKA) can be used. For patients with active cancer, DOACs are now recommended instead of LMWH. The length of anticoagulation is determined by whether the VTE was provoked or unprovoked, with treatment typically stopped after 3-6 months for provoked VTE and continued for up to 6 months for unprovoked VTE.
In cases of haemodynamic instability, thrombolysis is recommended as the first-line treatment for massive PE with circulatory failure. Patients who have repeat pulmonary embolisms, despite adequate anticoagulation, may be considered for inferior vena cava (IVC) filters. However, the evidence base for IVC filter use is weak.
Overall, the updated NICE guidelines provide clear recommendations for the management of PE, including the use of DOACs as first-line treatment and outpatient management for low-risk patients. The guidelines also emphasize the importance of individualized treatment based on risk stratification and balancing the risks of VTE recurrence and bleeding.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 12
Correct
-
A 70-year-old man comes to the clinic complaining of feeling tired and having palpitations for the last few days. Upon examination, his pulse is irregularly irregular and beats at a rate of 123 bpm. His blood pressure is 128/78 mmHg and his chest is clear. An ECG confirms that he has atrial fibrillation. What medication should be prescribed to manage his heart rate?
Your Answer: Bisoprolol
Explanation:When considering a rate control strategy for atrial fibrillation, factors such as age and symptoms should be taken into account. According to NICE guidelines, beta-blockers or rate limiting calcium channel blockers (excluding amlodipine) are preferable options.
Atrial fibrillation (AF) is a condition that requires careful management to prevent complications. The latest guidelines from NICE recommend that patients presenting with AF should be assessed for haemodynamic instability, and if present, electrically cardioverted. For haemodynamically stable patients, the management depends on how acute the AF is. If the AF has been present for less than 48 hours, rate or rhythm control may be considered. However, if it has been present for 48 hours or more, or the onset is uncertain, rate control is recommended. If long-term rhythm control is being considered, cardioversion should be delayed until the patient has been maintained on therapeutic anticoagulation for at least 3 weeks.
Rate control is the first-line treatment strategy for AF, except in certain cases. Medications such as beta-blockers, calcium channel blockers, and digoxin can be used to control the heart rate. However, digoxin is no longer considered first-line as it is less effective at controlling the heart rate during exercise. Rhythm control agents such as beta-blockers, dronedarone, and amiodarone can be used to maintain sinus rhythm in patients with a history of AF. Catheter ablation is recommended for those who have not responded to or wish to avoid antiarrhythmic medication.
The aim of catheter ablation is to ablate the faulty electrical pathways that are causing AF. The procedure is performed percutaneously, typically via the groin, and can use radiofrequency or cryotherapy to ablate the tissue. Anticoagulation should be used 4 weeks before and during the procedure. It is important to note that catheter ablation controls the rhythm but does not reduce the stroke risk, so patients still require anticoagulation as per their CHA2DS2-VASc score. Complications of catheter ablation can include cardiac tamponade, stroke, and pulmonary vein stenosis. The success rate of the procedure is around 50% for early recurrence within 3 months, and around 55% of patients who’ve had a single procedure remain in sinus rhythm after 3 years. Of patients who’ve undergone multiple procedures, around 80% are in sinus rhythm.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 13
Incorrect
-
A 63-year-old man presents to the Emergency Department with central crushing chest pain. Upon arrival, an ECG reveals ST-elevation in leads II, III and aVF. The patient has a history of hypertension and is currently taking ramipril, aspirin and simvastatin. What is the most effective course of action for managing this patient?
Your Answer: Aspirin + clopidogrel + LMWH + alteplase
Correct Answer: Aspirin + clopidogrel + IV heparin + immediate percutaneous coronary intervention
Explanation:Immediate percutaneous coronary intervention with aspirin, clopidogrel, and IV heparin is recommended.
Myocardial infarction, specifically ST-elevation myocardial infarction (STEMI), can be managed using evidence-based approaches. Patients without contraindications should be given aspirin and a P2Y12-receptor antagonist, with ticagrelor being preferred over clopidogrel due to improved outcomes despite slightly higher bleeding rates. Unfractionated heparin is typically given to patients undergoing percutaneous coronary intervention (PCI), but low-molecular weight heparin can also be used. Oxygen therapy should not be routinely administered, but supplemental oxygen can be given to patients with oxygen saturation levels below 94% or those with chronic obstructive pulmonary disease at risk of hypercapnic respiratory failure.
Primary PCI is the preferred treatment for STEMI, but it may not be available in all centers. Thrombolysis can be performed in patients without access to primary PCI, with tissue plasminogen activator (tPA) offering clear mortality benefits over streptokinase. Tenecteplase is easier to administer and has non-inferior efficacy to alteplase with a similar adverse effect profile. An ECG should be performed 90 minutes following thrombolysis to assess whether there has been a greater than 50% resolution in the ST elevation. If there has not been adequate resolution, rescue PCI is superior to repeat thrombolysis. For patients successfully treated with thrombolysis, PCI has been shown to be beneficial, but the optimal timing is still being investigated.
For patients with diabetes mellitus, NICE recommends using a dose-adjusted insulin infusion with regular monitoring of blood glucose levels to keep glucose below 11.0 mmol/l. Intensive insulin therapy regimes are not recommended routinely.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 14
Incorrect
-
A 54-year-old man with a history of untreated hypertension had a heart attack and received coronary stenting. He was prescribed multiple medications and his blood test results showed:
Na+ 140 mmol/l
K+ 6.2 mmol/l
Which of the following antihypertensive drugs could be causing this result?Your Answer: Indapamide
Correct Answer: Enalapril
Explanation:Hyperkalaemia is caused by ACE inhibitor.
Angiotensin-converting enzyme (ACE) inhibitors are commonly used as the first-line treatment for hypertension and heart failure in younger patients. However, they may not be as effective in treating hypertensive Afro-Caribbean patients. These inhibitors are also used to treat diabetic nephropathy and for secondary prevention of ischaemic heart disease. The mechanism of action of ACE inhibitors is to inhibit the conversion of angiotensin I to angiotensin II. They are metabolized in the liver through phase 1 metabolism.
ACE inhibitors may cause side effects such as cough, which occurs in around 15% of patients and may occur up to a year after starting treatment. This is thought to be due to increased bradykinin levels. Angioedema may also occur up to a year after starting treatment. Hyperkalaemia and first-dose hypotension are other potential side effects, especially in patients taking diuretics. ACE inhibitors should be avoided during pregnancy and breastfeeding, and caution should be exercised in patients with renovascular disease, aortic stenosis, or hereditary or idiopathic angioedema.
Patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day) are at an increased risk of hypotension when taking ACE inhibitors. Before initiating treatment, urea and electrolytes should be checked, and after increasing the dose, a rise in creatinine and potassium may be expected. Acceptable changes include an increase in serum creatinine up to 30% from baseline and an increase in potassium up to 5.5 mmol/l. Patients with undiagnosed bilateral renal artery stenosis may experience significant renal impairment. The current NICE guidelines provide a flow chart for the management of hypertension.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 15
Incorrect
-
A 65-year-old woman with a history of hypertension and heart failure presents with atrial fibrillation. She is stable with a ventricular rate of 70. Which of the following drug options would be the most suitable for her?
Your Answer: Digoxin
Correct Answer: Warfarin or direct oral anticoagulant (DOAC)
Explanation:Treatment Options for Atrial Fibrillation: Warfarin, DOACs, Aspirin, Digoxin, Furosemide, and Lidocaine
Patients with atrial fibrillation and a CHA2DS2-VASC score of 4 require anticoagulation to reduce the risk of a CVA. The two main options are warfarin and DOACs, but the choice depends on other co-morbidities and patient preference. Before starting warfarin, patients should be referred to the Anticoagulation Clinic and screened for contraindications.
Aspirin has no benefit in atrial fibrillation, and digoxin should only be used for short-term rate control due to evidence of increased mortality with long-term use. Furosemide can help with symptoms and edema in heart failure but does not improve mortality. Lidocaine is only appropriate for ventricular arrhythmias in unstable patients and requires specialist support.
In summary, the treatment options for atrial fibrillation vary depending on the patient’s individual circumstances and should be carefully considered by healthcare professionals.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 16
Correct
-
You are requested to evaluate a 65-year-old woman who has been admitted to your ward with a lower respiratory tract infection. She has a medical history of hypertension and gout and is currently taking amlodipine 10mg once daily and allopurinol 100mg once daily. You observe that her blood pressure has been consistently high over the past three days, with readings of 149/76 mmHg, 158/88 mmHg, and 150/82 mmHg. Which antihypertensive medication would be the most suitable to initiate?
Your Answer: Lisinopril
Explanation:For a patient with poorly controlled hypertension who is already taking a calcium channel blocker, the addition of an ACE inhibitor, angiotensin receptor blocker, or thiazide-like diuretic is recommended. In this case, since the patient’s hypertension remains uncontrolled, it is appropriate to start them on an ACE inhibitor or angiotensin receptor blocker, such as lisinopril. Atenolol would be a suitable option if the patient was already taking a calcium channel blocker, ACE inhibitor/ARB, and thiazide-like diuretic with a potassium level above 4.5 mmol/L. However, since the patient has a history of gout, thiazide-like diuretics like bendroflumethiazide and indapamide should be avoided as they can exacerbate gout symptoms.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 17
Incorrect
-
Which of the following treatments has not been demonstrated to enhance survival in individuals with persistent heart failure?
Your Answer: Spironolactone
Correct Answer: Furosemide
Explanation:Although furosemide is effective in treating the symptoms of both acute and chronic heart failure, it does not provide any predictive advantages.
Drug Management for Chronic Heart Failure: NICE Guidelines
Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.
Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 18
Correct
-
An 80-year-old woman is brought to the Emergency Department by her family. She has been experiencing increasing shortness of breath and low energy levels for the past 6 weeks. Upon arrival, an ECG reveals atrial fibrillation with a heart rate of 114 / min. Her blood pressure is 128/80 mmHg and a chest x-ray shows no abnormalities. What medication is recommended for controlling her heart rate?
Your Answer: Bisoprolol
Explanation:When it comes to rate control in atrial fibrillation, beta blockers are now the preferred option over digoxin. This is an important point to remember, especially for exams. The patient’s shortness of breath may be related to her heart rate and not necessarily a sign of heart failure, as her chest x-ray was normal. For more information, refer to the NICE guidelines.
Atrial fibrillation (AF) is a condition that requires careful management to prevent complications. The latest guidelines from NICE recommend that patients presenting with AF should be assessed for haemodynamic instability, and if present, electrically cardioverted. For haemodynamically stable patients, the management depends on how acute the AF is. If the AF has been present for less than 48 hours, rate or rhythm control may be considered. However, if it has been present for 48 hours or more, or the onset is uncertain, rate control is recommended. If long-term rhythm control is being considered, cardioversion should be delayed until the patient has been maintained on therapeutic anticoagulation for at least 3 weeks.
Rate control is the first-line treatment strategy for AF, except in certain cases. Medications such as beta-blockers, calcium channel blockers, and digoxin can be used to control the heart rate. However, digoxin is no longer considered first-line as it is less effective at controlling the heart rate during exercise. Rhythm control agents such as beta-blockers, dronedarone, and amiodarone can be used to maintain sinus rhythm in patients with a history of AF. Catheter ablation is recommended for those who have not responded to or wish to avoid antiarrhythmic medication.
The aim of catheter ablation is to ablate the faulty electrical pathways that are causing AF. The procedure is performed percutaneously, typically via the groin, and can use radiofrequency or cryotherapy to ablate the tissue. Anticoagulation should be used 4 weeks before and during the procedure. It is important to note that catheter ablation controls the rhythm but does not reduce the stroke risk, so patients still require anticoagulation as per their CHA2DS2-VASc score. Complications of catheter ablation can include cardiac tamponade, stroke, and pulmonary vein stenosis. The success rate of the procedure is around 50% for early recurrence within 3 months, and around 55% of patients who’ve had a single procedure remain in sinus rhythm after 3 years. Of patients who’ve undergone multiple procedures, around 80% are in sinus rhythm.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 19
Incorrect
-
A 52-year-old man of African ethnicity visits the GP after receiving results from ambulatory home blood pressure monitoring. The average reading was 152/96 mmHg, and he has no medical history. During today's visit, his heart rate is 78 bpm, blood pressure is 160/102 mmHg, and oxygen saturations are 97%. What should the GP do next?
Your Answer: Ramipril
Correct Answer: Nifedipine
Explanation:For a newly diagnosed patient of black African or African-Caribbean origin with hypertension, adding a calcium channel blocker (CCB) such as nifedipine is recommended as the first-line treatment. This is because ACE inhibitors and ARBs are less effective in patients of these ethnicities. Lifestyle advice alone is not sufficient if the patient’s average blood pressure reading on ambulatory monitoring is greater than 150/95 mmHg. Ramipril is not the first-line option for this patient population, and Losartan is a second-line option after CCBs.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 20
Correct
-
A 28-year-old man undergoes a routine electrocardiogram (ECG) as part of an examination at his local general practice surgery.
On examination, his pulse is 64 bpm and his blood pressure is 120/80 mmHg. The clinician notes a delta wave on the ECG and refers him to the Cardiology Department.
What is the most likely cause of this irregularity?Your Answer: Wolff-Parkinson-White (WPW) syndrome
Explanation:Wolff-Parkinson-White (WPW) syndrome is a condition where there is an extra electrical pathway in the heart, making the patient more susceptible to developing supraventricular tachycardia (SVT). The presence of delta waves, which are a slurred upstroke in the QRS complex, and a shortened PR interval are characteristic of WPW syndrome. Atrial fibrillation (AF), on the other hand, is an irregularly irregular pulse that is diagnosed by the absence of P waves and irregular QRS complexes on an ECG. Delta waves are not typically seen in AF unless the patient also has WPW syndrome. Sinus arrhythmia, which is an irregular rhythm, does not show delta waves on an ECG. Acute myocardial infarction (MI) is not associated with delta waves, but rather with ST elevation or depression and T wave inversion. Supraventricular tachycardia (SVT) is a regular narrow complex tachycardia that may or may not have delta waves, depending on whether the patient has underlying WPW syndrome.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 21
Incorrect
-
A 70-year-old man with a history of chronic heart failure due to ischaemic cardiomyopathy is being evaluated. He was discharged from the hospital two weeks ago after experiencing a heart attack. An echocardiogram conducted during his hospitalization revealed a left ventricular ejection fraction of 40%, but no valve issues were identified.
Despite his current regimen of furosemide, ramipril, carvedilol, aspirin, and simvastatin, he continues to experience shortness of breath with minimal exertion, such as walking 30 meters. On examination, his chest is clear, and there is only slight peripheral edema. What is the most appropriate next step in his management?Your Answer: Refer for cardiac resynchronisation therapy
Correct Answer: Add an aldosterone antagonist
Explanation:The 2010 NICE guidelines have been revised to recommend the use of both angiotensin-2 receptor blockers and hydralazine in combination with a nitrate as second-line treatments for heart failure, in addition to aldosterone antagonists. However, considering the patient’s recent myocardial infarction, the most appropriate option would be an aldosterone antagonist, as per the NICE guidelines. For further information, please refer to the guidelines.
Drug Management for Chronic Heart Failure: NICE Guidelines
Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.
Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 22
Incorrect
-
You have just received a 70-year-old man into the resuscitation room who had a witnessed collapse after complaining of chest pain. There was no pulse, and cardiopulmonary resuscitation (CPR) was performed at the scene. CPR is ongoing upon patient arrival in the Emergency Department. Pulse check demonstrates no palpable central pulse, and there is no respiratory effort. A 3-lead electrocardiogram (ECG) demonstrates no coordinated electrical activity or recognisable complexes, looking very much like a wandering flat line.
What is the most appropriate management of this patient?Your Answer: 1 mg of adrenaline 1 : 1000 intramuscularly (IM), and continue CPR
Correct Answer: 1 mg of adrenaline 1 : 10 000 intravenously (IV), and continue CPR
Explanation:Managing Cardiac Arrest: Correct and Incorrect Approaches
When dealing with a patient in cardiac arrest, it is crucial to follow the correct management protocol. In the case of a patient in asystole, CPR 30:2 (compressions: ventilations) should be initiated, along with 1 mg of adrenaline 10 ml of 1:10 000 IV every other cycle of CPR. Direct current (DC) shock is not indicated for asystole. Adrenaline 1:1000 IM is not appropriate for cardiac arrest situations, as it is used in anaphylaxis. External pacing is unlikely to be successful in the absence of P-wave asystole. Atropine is indicated in severe bradycardia, not asystole. It is essential to follow the correct approach to manage cardiac arrest effectively.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 23
Correct
-
A 56-year-old man with difficult hypertension comes to the GP clinic for follow-up. His average blood pressure over the past two weeks has been 168/100 mmHg and today in the clinic it is 176/102 mmHg. He is currently taking a combination of telmisartan 80 mg and hydrochlorothiazide 25mg tablets, as well as amlodipine 10mg daily. The latest laboratory results are as follows:
Na+ 136 mmol/L (135 - 145)
K+ 3.8 mmol/L (3.5 - 5.0)
Bicarbonate 25 mmol/L (22 - 29)
Urea 5 mmol/L (2.0 - 7.0)
Creatinine 135 µmol/L (55 - 120)
What would be the most appropriate next step?Your Answer: Add spironolactone
Explanation:For a patient with poorly controlled moderate hypertension who is already taking an ACE inhibitor, calcium channel blocker, and thiazide diuretic, the recommended next step would be to add spironolactone if their potassium level is less than 4.5mmol/L. Atenolol may be considered as a fourth-line agent if the potassium level is over 4.5mmol/L, but spironolactone is preferred according to NICE guidelines. Hydralazine should not be used outside of specialist care, and indapamide is not the best option as the patient is already taking a thiazide diuretic. Prazosin is an alternative to spironolactone, but spironolactone is preferred given the lower potassium level.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 24
Correct
-
An emergency buzzer sounds on the coronary care unit and you are the first doctor to respond. A healthcare assistant on an observation round has found a 72-year-old man unresponsive. You perform a head tilt and chin lift and check for a carotid pulse for 10 seconds while listening for breath sounds, but you detect neither.
Telemetry attached to the patient shows sinus rhythm at a rate of 110 bpm. The crash team is being summoned, and the crash trolley is being brought to the bedside. You are unaware of any DNACPR orders.
What is the most appropriate initial step?Your Answer: Start chest compressions at a rate of 30:2
Explanation:For a patient in cardiac arrest with a non-shockable rhythm (pulseless-electrical activity), the recommended ratio of chest compressions to ventilation is 30:2. Therefore, the initial action should be to start chest compressions at this rate. Administering 1 mg adrenaline or 300 mg amiodarone is inappropriate as the first step. Adrenaline may be given once chest compressions have started. Amiodarone is only indicated for patients in ventricular fibrillation or pulseless ventricular tachycardia. Delivering a single synchronised DC shock or three quick successive stacked unsynchronised DC shocks followed by 2 minutes of 30:2 compressions is incorrect for a patient in PEA, as these are only appropriate for a shockable rhythm while on telemetry.
The 2015 Resus Council guidelines for adult advanced life support outline the steps to be taken when dealing with patients with shockable and non-shockable rhythms. For both types of patients, chest compressions are a crucial part of the process, with a ratio of 30 compressions to 2 ventilations. Defibrillation is recommended for shockable rhythms, with a single shock for VF/pulseless VT followed by 2 minutes of CPR. Adrenaline and amiodarone are the drugs of choice for non-shockable rhythms, with adrenaline given as soon as possible and amiodarone administered after 3 shocks for VF/pulseless VT. Thrombolytic drugs should be considered if a pulmonary embolus is suspected. Atropine is no longer recommended for routine use in asystole or PEA. Oxygen should be titrated to achieve saturations of 94-98% following successful resuscitation. The Hs and Ts should be considered as potential reversible causes of cardiac arrest.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 25
Incorrect
-
A 57-year-old man of Indian descent presents for a hypertension follow-up. He presents a log of blood pressure readings he has taken at home, consistently showing values above 150/90 mmHg. He is currently taking amlodipine and atorvastatin, with optimal dosing for the past year. What would be the best course of action at this point?
Your Answer: Stop amlodipine and trial ramipril with indapamide instead
Correct Answer: Add indapamide
Explanation:The appropriate next step in the treatment of poorly controlled hypertension in a patient already taking a calcium channel blocker is to add a thiazide-like diuretic such as indapamide. This is in accordance with the NICE treatment algorithm, which recommends adding an ACE inhibitor, angiotensin-receptor-blocker, or thiazide-like diuretic in such cases. Adding a thiazide diuretic like bendroflumethiazide would be incorrect. Continuing blood pressure monitoring and reviewing in one month would not be appropriate, as the patient’s hypertension needs to be escalated. Similarly, stopping amlodipine and trialling ramipril with indapamide instead, or stopping amlodipine and trialling ramipril alone, would also be incorrect. The recommended approach is to add an ACE inhibitor or thiazide-like diuretic in combination with the calcium channel blocker.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 26
Correct
-
A 45-year-old woman presents to her General Practitioner (GP) with a 1-day history of intermittent chest pains. She states that these started in the afternoon and have gotten worse. The pain is central and seems to improve when she sits on her chair and leans forward. She has a past medical history of hypertension. The GP decides to perform an electrocardiogram (ECG).
Given the likely diagnosis, which of the following best describes what might be seen on the ECG?
Select the SINGLE most likely ECG finding from the list below.
Your Answer: Widespread concave ST-segment elevation and PR segment depression
Explanation:Understanding ECG Findings in Acute Pericarditis
Acute pericarditis is a condition that commonly presents with central pleuritic chest pain, relieved on leaning forward. One of the main ECG findings in acute pericarditis is widespread concave ST-segment elevations with PR-segment depression, which is 85% specific for the condition. Absent P waves are not typically caused by acute pericarditis, and ST-segment elevation in the anterior leads is more suggestive of anterior myocardial infarction. U waves are not characteristic ECG findings in acute pericarditis and are associated with other conditions. Other clinical features of acute pericarditis are largely dependent on the underlying cause. It is important to understand these ECG findings to aid in the diagnosis and management of acute pericarditis.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 27
Incorrect
-
A 70-year-old man presents with central chest pain that has been ongoing for 2 hours. The pain is radiating to his left arm. He has a medical history of hypertension and hypercholesterolemia.
Upon examination, the patient appears uncomfortable and sweaty. His vital signs are as follows:
- Heart rate: 90 bpm
- Respiratory rate: 20 breaths/min
- Peripheral oxygen saturation: 95% on room air
- Blood pressure: 136/78 mmHg
- Temperature: 37.0ºC
An ECG performed by the paramedics shows ST depression in leads II, III, and aVF, as well as T-wave inversion.
What is the immediate treatment that should be given?Your Answer: Aspirin, nitrate, morphine, oxygen
Correct Answer: Aspirin, nitrate, morphine
Explanation:The appropriate combination in this scenario is aspirin, nitrate, and morphine. The addition of oxygen is not necessary and may even be inappropriate. Ramipril and bisoprolol are not recommended for acute treatment but may be used for long-term management of ACS. Therefore, aspirin, nitrate, and oxygen is an incorrect combination, and morphine should also be included due to the patient’s significant pain. Oxygen should not be administered as the patient’s oxygen saturation levels are already adequate.
Managing Acute Coronary Syndrome: A Summary of NICE Guidelines
Acute coronary syndrome (ACS) is a common and serious medical condition that requires prompt management. The management of ACS has evolved over the years, with the development of new drugs and procedures such as percutaneous coronary intervention (PCI). The National Institute for Health and Care Excellence (NICE) has updated its guidelines on the management of ACS in 2020.
ACS can be classified into three subtypes: ST-elevation myocardial infarction (STEMI), non ST-elevation myocardial infarction (NSTEMI), and unstable angina. The management of ACS depends on the subtype. However, there are common initial drug therapies for all patients with ACS, such as aspirin and nitrates. Oxygen should only be given if the patient has oxygen saturations below 94%, and morphine should only be given for severe pain.
For patients with STEMI, the first step is to assess eligibility for coronary reperfusion therapy, which can be either PCI or fibrinolysis. Patients with NSTEMI/unstable angina require a risk assessment using the Global Registry of Acute Coronary Events (GRACE) tool to determine whether they need coronary angiography (with follow-on PCI if necessary) or conservative management.
This summary provides an overview of the NICE guidelines for managing ACS. The guidelines are complex and depend on individual patient factors, so healthcare professionals should review the full guidelines for further details. Proper management of ACS can improve patient outcomes and reduce the risk of complications.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 28
Correct
-
A 65-year-old man presents to the emergency department in the middle of the night with worsening pain in his left leg. The pain began at rest approximately 2 hours ago and has now become severe. The patient has a history of peripheral arterial disease and continues to smoke 10 cigarettes per day. Upon examination, the left lower limb appears pale and feels cold with no signs of edema or trauma. The dorsalis pedis and posterior tibial pulses are absent on palpation and inaudible on a doppler exam, while the right lower limb pulses are palpable. The patient has received IV morphine. What is the most appropriate initial management for this individual?
Your Answer: IV unfractionated heparin and urgent vascular review
Explanation:The appropriate initial management for acute limb ischaemia involves urgent vascular review and administration of IV unfractionated heparin for anticoagulation. The patient’s sudden onset of symptoms and absence of pulses on Doppler examination suggest arterial thrombosis, which is a surgical emergency. Low molecular weight heparin and a lower limb venous ultrasound scan are not indicated, as the thrombus is likely arterial. Similarly, ankle-brachial pressure index and imaging studies such as CT or lower limb arterial Doppler ultrasound should not delay urgent vascular review in this critical situation.
Peripheral arterial disease can present in three main ways: intermittent claudication, critical limb ischaemia, and acute limb-threatening ischaemia. The latter is characterized by one or more of the 6 P’s: pale, pulseless, painful, paralysed, paraesthetic, and perishing with cold. Initial investigations include a handheld arterial Doppler examination and an ankle-brachial pressure index (ABI) if Doppler signals are present. It is important to determine whether the ischaemia is due to a thrombus or embolus, as this will guide management. Thrombus is suggested by pre-existing claudication with sudden deterioration, reduced or absent pulses in the contralateral limb, and evidence of widespread vascular disease. Embolus is suggested by a sudden onset of painful leg (<24 hours), no history of claudication, clinically obvious source of embolus, and no evidence of peripheral vascular disease. Initial management includes an ABC approach, analgesia, intravenous unfractionated heparin, and vascular review. Definitive management options include intra-arterial thrombolysis, surgical embolectomy, angioplasty, bypass surgery, or amputation for irreversible ischaemia.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 29
Correct
-
A 40-year-old man comes to the emergency department after experiencing syncope. Upon conducting an ECG, it is found that he has sinus rhythm with a rate of 85 bpm. The QRS duration is 110 ms, PR interval is 180 ms, and corrected QT interval is 500ms. What is the reason for the abnormality observed on the ECG?
Your Answer: Hypokalaemia
Explanation:Long QT syndrome can be caused by hypokalaemia, which is an electrolyte imbalance that leads to a prolonged corrected QT interval on an ECG. This condition is often seen in young people and can present as cardiac syncope, tachyarrhythmias, palpitations, or cardiac arrest. Long QT syndrome can be inherited or acquired, with hypokalaemia being one of the acquired causes. Other causes include medications, CNS lesions, malnutrition, and hypothermia. It’s important to note that hypercalcaemia is associated with a shortened QT interval, not a prolonged one.
Understanding Long QT Syndrome
Long QT syndrome (LQTS) is a genetic condition that causes delayed repolarization of the ventricles, which can lead to ventricular tachycardia and sudden death. The most common types of LQTS are caused by defects in the alpha subunit of the slow delayed rectifier potassium channel. A normal corrected QT interval is less than 430 ms in males and 450 ms in females.
There are various causes of a prolonged QT interval, including congenital factors, drugs, and other medical conditions. Some drugs that can prolong the QT interval include amiodarone, tricyclic antidepressants, and selective serotonin reuptake inhibitors. Electrolyte imbalances, acute myocardial infarction, and subarachnoid hemorrhage can also cause a prolonged QT interval.
LQTS may be picked up on routine ECG or following family screening. The symptoms and events associated with LQTS can vary depending on the type of LQTS. Long QT1 is usually associated with exertional syncope, while Long QT2 is often associated with syncope following emotional stress or exercise. Long QT3 events often occur at night or at rest.
Management of LQTS involves avoiding drugs that prolong the QT interval and other precipitants if appropriate. Beta-blockers may be used, and in high-risk cases, implantable cardioverter defibrillators may be necessary. It is important to recognize and manage LQTS to prevent sudden cardiac death.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 30
Incorrect
-
A 75 year old man with congestive cardiac failure is seen in cardiology clinic. He reports persistent shortness of breath with minimal activity. His current medications consist of furosemide, ramipril, bisoprolol, and spironolactone. An ECHO reveals an ejection fraction of 30%, while an ECG shows sinus rhythm with a QRS duration of 150ms. What is the optimal approach to enhance mortality?
Your Answer: Digoxin
Correct Answer: Cardiac resynchronisation therapy
Explanation:Heart failure patients with a left ventricular ejection fraction of less than or equal to 40% and symptoms no more severe than class III according to the New York Heart Association functional classification may benefit from digoxin in terms of reducing hospitalization. However, it does not have an impact on mortality. While increasing the dosage of furosemide may provide relief from fluid overload symptoms, it does not affect mortality.
Non-Drug Management for Chronic Heart Failure
Chronic heart failure is a condition that requires long-term management to improve symptoms and reduce hospitalization. While medication is often the first line of treatment, non-drug management options are also available. Two such options are cardiac resynchronization therapy and exercise training.
Cardiac resynchronization therapy involves biventricular pacing for patients with heart failure and wide QRS. This therapy has been shown to improve symptoms and reduce hospitalization in patients with NYHA class III heart failure. By synchronizing the heart’s contractions, this therapy can improve the heart’s pumping ability and reduce symptoms such as shortness of breath and fatigue.
Exercise training is another non-drug management option for chronic heart failure. While it may not reduce hospitalization or mortality rates, it has been shown to improve symptoms. Exercise can help improve the heart’s ability to pump blood and increase overall fitness levels. This can lead to a reduction in symptoms such as fatigue and shortness of breath, allowing patients to engage in daily activities with greater ease.
Overall, non-drug management options such as cardiac resynchronization therapy and exercise training can be effective in managing chronic heart failure. These options can improve symptoms and quality of life for patients, reducing the need for hospitalization and improving overall health outcomes.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 31
Correct
-
A 55-year-old caucasian man comes in for his annual hypertension check-up. He has already completed a blood pressure diary at home, which shows an average daytime reading of 160/100 mmHg. During his visit today, his blood pressure is measured at 174/110 mmHg. He is currently taking ramipril 10mg daily and is fully compliant with his medication.
In addition to hypertension, he has a history of recurrent gout and takes allopurinol for it. He has no other medical issues. Since his hypertension diagnosis, he has quit smoking and has taken steps to improve his lifestyle.
What would be the most appropriate course of action?Your Answer: Add nifedipine
Explanation:If a patient with hypertension is already on an ACE inhibitor and has a history of gout, it would be more appropriate to prescribe a calcium channel blocker rather than a thiazide as the next step in treatment. Nifedipine is the recommended choice for this patient. The target blood pressure for adults under 80 years old with hypertension is below 140/90 mmHg. If a single medication is not controlling the patient’s blood pressure, a second agent should be considered after checking treatment adherence. For a Caucasian man under 55 years old, the first step in treatment is an ACE inhibitor or an ARB. The second step is the addition of a CCB or thiazide-like diuretic, depending on clinical factors. However, in this case, the patient’s history of gout makes nifedipine a more appropriate choice than bendroflumethiazide. Doxazosin is not recommended for stage 2 hypertension, and losartan should not be used together with an ACE inhibitor. Lifestyle changes and repeat blood pressure in 3 months are not sufficient at this stage, as a single medication may not be enough to control hypertension.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 32
Incorrect
-
Which one of the following patients should not be prescribed a statin without any contraindication?
Your Answer: A 51-year-old man who had a myocardial infarction 4 years ago and is now asymptomatic
Correct Answer: A 57-year-old man with well controlled diabetes mellitus type 2 with a 10-year cardiovascular risk of 8%
Explanation:Statins are drugs that inhibit the action of an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. However, they can cause some adverse effects such as myopathy, which includes muscle pain, weakness, and damage, and liver impairment. Myopathy is more common in lipophilic statins than in hydrophilic ones. Statins may also increase the risk of intracerebral hemorrhage in patients who have had a stroke before. Therefore, they should be avoided in these patients. Statins should not be taken during pregnancy and should be stopped if the patient is taking macrolides.
Statins are recommended for people with established cardiovascular disease, those with a 10-year cardiovascular risk of 10% or more, and patients with type 2 diabetes mellitus. Patients with type 1 diabetes mellitus who were diagnosed more than 10 years ago, are over 40 years old, or have established nephropathy should also take statins. It is recommended to take statins at night as this is when cholesterol synthesis takes place. Atorvastatin 20mg is recommended for primary prevention, and the dose should be increased if non-HDL has not reduced for 40% or more. Atorvastatin 80 mg is recommended for secondary prevention.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 33
Correct
-
You perform a medication review for a 75-year-old woman who comes in for a regular check-up. She has a medical history of ischaemic heart disease, stage 2 CKD, hypertension, and gout. Despite her conditions, she is able to function well on her own and her blood pressure today is 125/72 mmHg. Which medication would you suggest discontinuing?
Your Answer: Bendroflumethiazide
Explanation:Assessing medications in elderly patients can be challenging, as they may be taking unnecessary or harmful drugs. The STOPP-START Criteria (Gallagher et al., 2008) provides guidance on medications that should be considered for discontinuation in the elderly. In this case, the patient has gout, which can be aggravated by bendroflumethiazide, an outdated thiazide diuretic that is no longer recommended by NICE. Additionally, her blood pressure is well below the target for her age, which is 150/90 mmHg in clinic. Ramipril is a more suitable antihypertensive medication to continue for now, but it may also be discontinued if her blood pressure remains low. The patient requires aspirin and atorvastatin for her ischemic heart disease, and allopurinol for her gout.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 34
Correct
-
A 55-year-old man comes to see his GP complaining of a dry cough that has been going on for 3 weeks. He reports no chest pain or shortness of breath, and has not experienced any unexplained weight loss. The patient has a history of type 2 diabetes mellitus that is managed through lifestyle and diet, and was recently diagnosed with hypertension and started on lisinopril. He is a non-smoker and drinks 6 units of alcohol per week. What is the best course of action for his treatment?
Your Answer: Stop lisinopril and start irbesartan
Explanation:When a patient cannot tolerate taking ACE inhibitors, such as lisinopril, an angiotensin-receptor blocker (ARB) should be offered as an alternative, according to NICE guidelines. This is particularly relevant for patients with a medical history of type 2 diabetes mellitus, as an ACE inhibitor is preferred due to its renal protective and antihypertensive properties. In this case, the patient is likely experiencing a dry cough as a side effect of lisinopril use, which is a common issue with ACE inhibitors. To address this, stopping lisinopril and starting irbesartan is the correct course of action. Unlike ACE inhibitors, ARBs do not cause a buildup of bradykinin in the lungs, which is responsible for the dry cough. It is important to note that reassurance alone is not sufficient, as the dry cough will not settle with time. Additionally, arranging a skin prick allergy test is unnecessary, as the patient is not allergic to lisinopril. While amlodipine may be considered as a second-line treatment option, NICE recommends switching to an ARB first.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 35
Incorrect
-
An 80-year-old man with a history of hypertension and ischaemic heart disease comes in for a check-up. He had a heart attack two decades ago but has been symptom-free since. His current medications include bisoprolol, ramipril, atorvastatin, and clopidogrel. He has been experiencing dizziness lately, and an ECG reveals that he has atrial fibrillation. What is the appropriate antithrombotic medication for him now?
Your Answer: Switch to an oral anticoagulant + clopidogrel
Correct Answer: Switch to an oral anticoagulant
Explanation:Patients who have AF and stable CVD are typically prescribed anticoagulants while antiplatelets are discontinued. This is because such patients are at risk of stroke, as indicated by their CHADS-VASC score, which takes into account factors such as age, hypertension, and cardiovascular disease. Therefore, the patient in question needs to be treated accordingly. In this case, the patient should discontinue their antiplatelet medication and switch to oral anticoagulant monotherapy.
Managing Combination Antiplatelet and Anticoagulant Therapy
With the rise of comorbidity, it is becoming increasingly common for patients to require both antiplatelet and anticoagulant therapy. However, this combination increases the risk of bleeding and may not be necessary in all cases. While there are no guidelines to cover every scenario, a recent review in the BMJ offers expert opinion on how to manage this situation.
For patients with stable cardiovascular disease who require an anticoagulant, it is recommended that they receive antiplatelet therapy as well. However, if the patient has an indication for an anticoagulant, such as atrial fibrillation, it is best to prescribe anticoagulant monotherapy without the addition of antiplatelets.
In patients who have experienced an acute coronary syndrome or undergone percutaneous coronary intervention, there is a stronger indication for antiplatelet therapy. Typically, patients are given triple therapy (two antiplatelets and one anticoagulant) for four to six months after the event, followed by dual therapy (one antiplatelet and one anticoagulant) for the remaining 12 months. However, the stroke risk in atrial fibrillation varies according to risk factors, so there may be variation in treatment from patient to patient.
For patients who develop venous thromboembolism while on antiplatelets, they will likely be prescribed anticoagulants for three to six months. An ORBIT score should be calculated to determine the risk of bleeding. Patients with a low risk of bleeding may continue taking antiplatelets, while those with an intermediate or high risk of bleeding should consider stopping them.
Overall, managing combination antiplatelet and anticoagulant therapy requires careful consideration of the patient’s individual circumstances and risk factors.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 36
Correct
-
An 80-year-old man visits his GP for a medication review. His blood pressure is measured at 184/72 and this is verified twice. What would be the most suitable initial treatment?
Your Answer: Amlodipine
Explanation:According to the 2011 NICE guidelines, the treatment for isolated systolic hypertension should be the same as that for standard hypertension, with calcium channel blockers being the preferred first-line medication for this age group.
Understanding Isolated Systolic Hypertension
Isolated systolic hypertension (ISH) is a common condition among the elderly, affecting approximately 50% of individuals over the age of 70. The Systolic Hypertension in the Elderly Program (SHEP) conducted in 1991 found that treating ISH can reduce the risk of strokes and ischaemic heart disease. The first line of treatment for ISH was thiazides. However, the 2011 NICE guidelines recommend treating ISH in the same stepwise manner as standard hypertension, which contradicts the previous approach.
It is important to understand ISH as it is a prevalent condition among the elderly population. The SHEP study showed that treating ISH can significantly reduce the risk of serious health complications. However, the recommended approach to treating ISH has changed over time, with the 2011 NICE guidelines suggesting a different method than the previous recommendation of using thiazides as the first line of treatment. It is crucial for healthcare professionals to stay up-to-date with the latest guidelines to provide the best possible care for patients with ISH.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 37
Correct
-
Which of the following types of anti-anginal medication do patients frequently develop tolerance to?
Your Answer: Standard release isosorbide mononitrate
Explanation:Angina pectoris is a condition that can be managed through various methods, including lifestyle changes, medication, percutaneous coronary intervention, and surgery. In 2011, NICE released guidelines for the management of stable angina. Medication is an important aspect of treatment, and all patients should receive aspirin and a statin unless there are contraindications. Sublingual glyceryl trinitrate can be used to abort angina attacks. The first-line medication should be either a beta-blocker or a calcium channel blocker, depending on the patient’s comorbidities, contraindications, and preferences. If a calcium channel blocker is used as monotherapy, a rate-limiting one such as verapamil or diltiazem should be used. If used in combination with a beta-blocker, a longer-acting dihydropyridine calcium channel blocker should be used. Beta-blockers should not be prescribed concurrently with verapamil due to the risk of complete heart block. If the initial treatment is not effective, medication should be increased to the maximum tolerated dose. If a patient is still symptomatic after monotherapy with a beta-blocker, a calcium channel blocker can be added, and vice versa. If a patient cannot tolerate the addition of a calcium channel blocker or a beta-blocker, other drugs such as long-acting nitrates, ivabradine, nicorandil, or ranolazine can be considered. Nitrate tolerance is a common issue, and patients who take standard-release isosorbide mononitrate should use an asymmetric dosing interval to maintain a daily nitrate-free time of 10-14 hours to minimize the development of nitrate tolerance. This effect is not seen in patients who take once-daily modified-release isosorbide mononitrate. If a patient is taking both a beta-blocker and a calcium-channel blocker, a third drug should only be added while awaiting assessment for PCI or CABG.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 38
Incorrect
-
A 50-year-old man presents to you after experiencing a heart attack 4 weeks ago. He has been prescribed ramipril, bisoprolol, aspirin, and clopidogrel following the event. Although he was offered a statin, he declined it at the time, feeling that he was being asked to take too many medications simultaneously. He has since read about the advantages of being on a statin and wishes to begin statin therapy. What is the appropriate statin for this patient to start on?
Your Answer: Atorvastatin 20mg
Correct Answer: Atorvastatin 80mg
Explanation:For primary prevention of cardiovascular disease, a dosage of 20mg of atorvastatin is recommended. However, for secondary prevention, a higher dosage of 80 mg is recommended.
Statins are drugs that inhibit the action of an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. However, they can cause some adverse effects such as myopathy, which includes muscle pain, weakness, and damage, and liver impairment. Myopathy is more common in lipophilic statins than in hydrophilic ones. Statins may also increase the risk of intracerebral hemorrhage in patients who have had a stroke before. Therefore, they should be avoided in these patients. Statins should not be taken during pregnancy and should be stopped if the patient is taking macrolides.
Statins are recommended for people with established cardiovascular disease, those with a 10-year cardiovascular risk of 10% or more, and patients with type 2 diabetes mellitus. Patients with type 1 diabetes mellitus who were diagnosed more than 10 years ago, are over 40 years old, or have established nephropathy should also take statins. It is recommended to take statins at night as this is when cholesterol synthesis takes place. Atorvastatin 20mg is recommended for primary prevention, and the dose should be increased if non-HDL has not reduced for 40% or more. Atorvastatin 80 mg is recommended for secondary prevention. The graphic shows the different types of statins available.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 39
Incorrect
-
A 26-year-old woman gives birth vaginally at 38 weeks gestation and chooses to have a physiological third stage of labor. She experiences a blood loss of 800 ml shortly after delivery. The medical team follows an ABCDE approach and starts a warmed crystalloid infusion. There is no history of medical issues or delivery-related trauma.
What should be the next course of action in managing her condition?Your Answer: Give IV oxytocin
Correct Answer: Compress the uterus and catheterise her
Explanation:To manage a postpartum haemorrhage, an ABCDE approach should be taken, with initial steps including compressing the uterus and catheterising the patient. This is known as ‘mechanical management’ and is appropriate for a primary postpartum haemorrhage (PPH) where uterine atony is the most common cause. IV warmed crystalloid should also be given. Medical management options such as IV oxytocin or IM/IV carboprost should only be considered if mechanical methods fail. It is important to note that IV carboprost should not be administered as it can lead to serious side effects.
Understanding Postpartum Haemorrhage
Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.
In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.
Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 40
Correct
-
A 25-year-old woman presents with recurrent syncope following aerobics classes. On examination, a systolic murmur is heard that worsens with the Valsalva manoeuvre and improves on squatting. What is the most likely diagnosis?
Your Answer: Hypertrophic cardiomyopathy (HCM)
Explanation:Differentiating Causes of Syncope: A Guide
Syncope, or fainting, can be caused by a variety of underlying conditions. One such condition is hypertrophic cardiomyopathy (HCM), which often presents with syncope following exercise. Patients with HCM may also have a mid-systolic murmur and a jerky pulse, which worsens with Valsalva but improves with squatting.
Atrial fibrillation, on the other hand, typically presents with palpitations, fatigue, or shortness of breath, but not syncope. It does not cause a murmur and results in an irregularly irregular pulse.
Epilepsy is not a common cause of syncope, as typical seizures involve loss of consciousness, tensing, shaking, and postictal fatigue.
Aortic stenosis can cause dizziness and syncope, and is usually associated with angina. The murmur associated with aortic stenosis is a crescendo-decrescendo murmur that radiates to the carotids.
A vasovagal attack, while it can cause syncope, would not cause a murmur. If syncope is recurrent, other causes should be sought.
Dyspnea is a common complaint in patients with HCM, but they may also experience angina or syncope. A left ventricular apical impulse, a prominent S4 gallop, and a harsh systolic ejection murmur are typical findings. The Valsalva maneuver can increase the murmur. An echocardiogram is the diagnostic procedure of choice.
Most patients with aortic stenosis have gradually increasing obstruction for years but do not become symptomatic until their sixth to eighth decades.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 41
Incorrect
-
A 16-year-old boy with Marfan syndrome is seen in the Cardiology Clinic. He has been researching possible complications of his condition online and is worried about potential cardiac issues.
Which of the following cardiac abnormalities is most probable in this patient?Your Answer: Pulmonary regurgitation
Correct Answer: Aortic regurgitation
Explanation:Cardiac Abnormalities Associated with Marfan Syndrome
Marfan syndrome is commonly associated with cardiac abnormalities, with aortic root dilatation being the most prevalent, found in approximately 80% of cases. This can lead to aortic regurgitation and even dissection. While there is some evidence of a slight increase in atrial septal defects in Marfan syndrome patients, it is not as common as aortic regurgitation or mitral valve prolapse. Dilated cardiomyopathy can also present in Marfan syndrome patients, although it is not as prevalent as aortic root dilatation or regurgitation. Pulmonary regurgitation is also increased in incidence in Marfan syndrome, but it is still less common than aortic regurgitation. Finally, while persistent ductus arteriosus is more commonly found in Marfan syndrome patients than in the general population, the association is relatively weak. Overall, Marfan syndrome patients should be monitored closely for these cardiac abnormalities to ensure proper management and treatment.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 42
Correct
-
A 48-year-old man is attending the hypertension clinic. He was diagnosed approximately three months ago and commenced on ramipril. Despite titrating up to 10mg od, his blood pressure remains at 156/92 mmHg. What is the next best course of action in managing his hypertension?
Your Answer: Add amlodipine OR indapamide
Explanation:To improve control of hypertension in patients who are already taking an ACE inhibitor or an angiotensin receptor blocker, the 2019 NICE guidelines recommend adding either a calcium channel blocker (such as amlodipine) or a thiazide-like diuretic (such as indapamide). This is a change from previous guidelines, which only recommended adding a calcium channel blocker in this situation.
NICE Guidelines for Managing Hypertension
Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.
The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.
NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.
New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 43
Incorrect
-
A 65-year-old overweight man presents with worsening shortness of breath and leg swelling due to advanced heart failure. His kidney function is normal and his potassium level is 4.2 mmol/l. Which combination of medications would provide the greatest mortality benefit for him?
Your Answer: Ramipril, furosemide, bendroflumethiazide and atenolol
Correct Answer: Ramipril and bisoprolol
Explanation:There are several medications used to treat heart failure, including ACE inhibitors and beta-blockers, which have been shown to provide a mortality benefit. However, ACE inhibitors can cause hyperkalaemia, so potassium levels should be monitored closely when starting. If ACE inhibitors are not tolerated, angiotensin II receptor antagonists can be used instead. Atenolol is not recommended for use in heart failure, and agents typically used are bisoprolol, carvedilol, or metoprolol. Diuretics like furosemide and bendroflumethiazide provide symptom relief but do not improve mortality. When used together, they have a potent diuretic effect that may be required when patients accumulate fluid despite an adequate furosemide dose. However, this combination provides no long-term mortality benefit. It is important to note that decisions regarding medication management should be made by a specialist.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 44
Correct
-
A 28-year-old professional basketball player presents with complaints of feeling lightheaded during exercise. Upon physical examination, a laterally displaced apical impulse is noted. Auscultation reveals a 2/6 mid-systolic murmur in the mitral area that increases upon sudden standing. The ECG shows LVH and Q waves in V1–4 leads.
What is the most probable diagnosis?Your Answer: Hypertrophic cardiomyopathy
Explanation:Differential Diagnosis for a Patient with Dyspnoea and a Murmur: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy is a condition that can lead to sudden death in young athletes and is characterized by dyspnoea, LVH, and a loud S4. The systolic murmur associated with hypertrophic cardiomyopathy does not radiate to the carotids and can be differentiated from aortic stenosis, which causes a crescendo-decrescendo murmur that does radiate to the carotids. Young-onset hypertension is unlikely to cause a murmur, and acute myocardial infarction would show ST elevation or depression on ECG, but not LVH. Atrial septal defect is usually picked up in newborn checks and presents with a brief murmur in early systole and early diastole, while hypertrophic cardiomyopathy presents with a double or triple apical impulse and a characteristic jerky carotid pulse. It is important to recognize the symptoms and signs of hypertrophic cardiomyopathy to prevent sudden death in young athletes.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 45
Correct
-
A 61-year-old man presents to the emergency department after experiencing syncope. Upon assessment, his respiratory rate is 20/min, heart rate is 170/min, and BP is 78/40 mmHg. An ECG reveals a regular tachycardia with a wide complex. The patient is given a peripheral venous line, blood is drawn, and an ECG monitor is attached. What is the next best course of action for managing this patient?
Your Answer: DC cardioversion
Explanation:Given the patient’s syncope, low BP, and regular wide complex tachycardia, which is likely to be ventricular tachycardia, the appropriate next step is DC cardioversion since the systolic BP is below 90 mmHg. Adenosine is not relevant in this scenario as it is used for managing narrow complex regular tachycardia with no adverse features. Amiodarone is an antiarrhythmic medication that could be used to treat ventricular tachycardia, but it is not appropriate in this case due to the patient’s syncope and low BP.
Management of Peri-Arrest Tachycardias
The Resuscitation Council (UK) guidelines for the management of peri-arrest tachycardias have been simplified in the 2015 update. The previous separate algorithms for broad-complex tachycardia, narrow complex tachycardia, and atrial fibrillation have been replaced by a unified treatment algorithm. After basic ABC assessment, patients are classified as stable or unstable based on the presence of adverse signs such as hypotension, pallor, sweating, confusion, or impaired consciousness. If any of these signs are present, synchronised DC shocks should be given, up to a maximum of three shocks.
The treatment following this is based on whether the QRS complex is narrow or broad and whether the rhythm is regular or irregular. For broad-complex tachycardia, a loading dose of amiodarone followed by a 24-hour infusion is given if the rhythm is regular. If the rhythm is irregular, expert help should be sought as it could be due to atrial fibrillation with bundle branch block, atrial fibrillation with ventricular pre-excitation, or torsade de pointes.
For narrow-complex tachycardia, vagal manoeuvres followed by IV adenosine are given if the rhythm is regular. If unsuccessful, atrial flutter is considered, and rate control is achieved with beta-blockers. If the rhythm is irregular, it is likely due to atrial fibrillation, and electrical or chemical cardioversion is considered if the onset is less than 48 hours. Beta-blockers are usually the first-line treatment for rate control unless contraindicated. The full treatment algorithm can be found on the Resuscitation Council website.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 46
Incorrect
-
A 57-year-old woman visits her GP complaining of a painful, red left thigh. She denies feeling unwell and reports no shortness of breath or haemoptysis. Her medical history includes obesity (BMI 32 kg/m2) and no past surgeries. She takes no regular medications. On examination, she appears healthy, and all her vital signs are normal. She has erythema on the medial aspect of her left thigh. Palpation of the left long saphenous vein reveals tenderness and hardening over a 6 cm length, starting 10cm distal to the sapheno-femoral junction. The Wells score for DVT is 1. What is the most appropriate next step in investigation?
Your Answer: Blood lipid profile
Correct Answer: Venous ultrasound of the legs
Explanation:Patients diagnosed with superficial thrombophlebitis in the long saphenous vein should undergo an ultrasound scan to rule out the possibility of an underlying DVT. While this condition is typically harmless and can be treated with NSAIDs and compression, it carries a risk of DVT and subsequent PE. Therefore, it is recommended that patients with proximal long saphenous vein thrombophlebitis undergo an ultrasound to exclude DVT.
In this case, there are no indications of PE or respiratory symptoms, so a CTPA or chest X-ray is not necessary. While a D-dimer test is typically used to diagnose DVT, it is not useful in the presence of superficial thrombophlebitis. As a result, the guideline is to proceed directly to venous ultrasound.
The risk factors for superficial thrombophlebitis are the same as those for DVT/PE, such as female sex, prolonged immobility, obesity, and cancer. While checking blood lipid levels may be relevant, it is not a primary concern as this is a thrombotic rather than an atherosclerotic process.
Superficial thrombophlebitis is inflammation associated with thrombosis of a superficial vein, usually the long saphenous vein of the leg. Around 20% of cases have an underlying deep vein thrombosis (DVT) and 3-4% may progress to a DVT if untreated. Treatment options include NSAIDs, topical heparinoids, compression stockings, and low-molecular weight heparin. Patients with clinical signs of superficial thrombophlebitis affecting the proximal long saphenous vein should have an ultrasound scan to exclude concurrent DVT. Patients with superficial thrombophlebitis at, or extending towards, the sapheno-femoral junction can be considered for therapeutic anticoagulation for 6-12 weeks.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 47
Incorrect
-
A 65-year-old man experiences percutaneous coronary intervention for an ST-elevation myocardial infarction. After 12 hours, he develops symptoms of paleness, clamminess, and bradycardia, and the ECG reveals complete disassociation between the atria and ventricles. Which coronary artery is the most probable culprit?
Your Answer: Left anterior descending coronary artery
Correct Answer: Right coronary artery
Explanation:The left main coronary artery is not the cause of heart block. It usually results in anterior myocardial infarction.
Understanding Heart Blocks and their Features
Heart blocks are a type of cardiac conduction disorder that can lead to a range of symptoms and complications. There are three types of heart blocks, each with distinct features and characteristics. First-degree heart block is characterized by a prolonged PR interval, while second-degree heart block can be further divided into two subtypes: Mobitz I and Mobitz II. Mobitz I is characterized by a progressive prolongation of the PR interval until a dropped beat occurs, while Mobitz II is characterized by a constant PR interval but often not followed by a QRS complex.
The most severe form of heart block is third-degree or complete heart block, which is characterized by a complete dissociation between the P waves and QRS complexes. This can lead to a range of symptoms, including syncope, heart failure, regular bradycardia, and wide pulse pressure. Other features of complete heart block include cannon waves in the neck and variable intensity of S1.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 48
Incorrect
-
A 58-year-old man with a history of diabetes mellitus presents to his General Practitioner with a heavy feeling in his chest for the past two hours. An electrocardiogram (ECG) is taken, which shows 1.4 mm ST-segment elevations in leads II III and aVF.
Which of the following is the most likely diagnosis?Your Answer: Posterior MI
Correct Answer: Inferior MI
Explanation:Based on the electrocardiogram (ECG) findings, the most likely diagnosis for this patient is an inferior myocardial infarction (MI), which occurs in the territory of the right coronary artery. This is indicated by ST-segment elevations in leads I, II, and aVF. Other ECG changes, such as complete heart block and bradycardia, may also be present due to the arterial supply the RCA gives to the atrioventricular and sinoatrial nodes. It is important to note that a new left bundle branch block (LBBB) may suggest acute coronary syndrome.
Acute pericarditis is unlikely as it presents with sharp retrosternal chest pain and a pericardial friction rub on auscultation, with different ECG findings such as widespread concave ST-segment elevations and PR segment depression.
An anterolateral MI would show ST-segment elevations in the anterolateral leads, while a posterior MI would show ST-segment depressions in the anterior leads with tall R waves.
In a pulmonary embolism (PE), ECG changes may include a large S wave in lead I, a large Q wave in lead III, and an inverted T wave in lead III – S1Q3T3, but this is only seen in a minority of patients. Most patients with a PE would have a normal ECG or sinus tachycardia, with signs of right-heart strain sometimes present. The clinical presentation of a PE would also differ from that of an MI, with symptoms such as tachypnea, tachycardia, lung crackles, fever, pleuritic chest pain, dyspnea, and hemoptysis.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 49
Correct
-
An 80-year-old man presents with leg swelling and nocturnal dyspnea. His BNP levels are elevated and an echocardiogram confirms heart failure with reduced ejection fraction. He has a history of diabetes and is currently on metformin. Besides furosemide, what other medication should be initiated for his heart failure management?
Your Answer: Ramipril
Explanation:When treating heart failure patients, it is recommended to initiate therapy with either an angiotensin-converting enzyme (ACE) inhibitor or a beta-blocker licensed for heart failure treatment, but not both simultaneously. If the patient exhibits signs of fluid overload or has diabetes mellitus, an ACE inhibitor like ramipril is preferred. On the other hand, if the patient has angina, a beta-blocker such as bisoprolol, carvedilol, or nebivolol is preferred.
Drug Management for Chronic Heart Failure: NICE Guidelines
Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.
Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.
-
This question is part of the following fields:
- Cardiovascular
-
-
Question 50
Incorrect
-
A 70-year-old man is rushed to the hospital due to severe chest pain and nausea. His ECG reveals ST elevation in leads V1, V2, V3, and V4. Following angiography and percutaneous coronary intervention, his left anterior descending coronary artery is stented. The patient admits to avoiding doctors and not seeing his GP for more than two decades. He has been smoking 15 cigarettes daily since he was 18. What are the recommended medications for secondary prevention?
Your Answer: Aspirin + apixaban + ramipril + bisoprolol + atorvastatin
Correct Answer: Aspirin + prasugrel + lisinopril + bisoprolol + atorvastatin
Explanation:Myocardial infarction (MI) is a serious condition that requires proper management to prevent further complications. In 2013, NICE released guidelines on the secondary prevention of MI. One of the key recommendations is the use of four drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent), ACE inhibitor, beta-blocker, and statin. Patients are also advised to adopt a Mediterranean-style diet and engage in regular exercise. Sexual activity may resume four weeks after an uncomplicated MI, and PDE5 inhibitors may be used six months after the event.
Most patients with acute coronary syndrome are now given dual antiplatelet therapy, with ticagrelor and prasugrel being the preferred options. The treatment period for these drugs is 12 months, after which they should be stopped. However, this period may be adjusted for patients at high risk of bleeding or further ischaemic events. Additionally, patients with heart failure and left ventricular systolic dysfunction should be treated with an aldosterone antagonist within 3-14 days of the MI, preferably after ACE inhibitor therapy.
Overall, the NICE guidelines provide a comprehensive approach to the secondary prevention of MI. By following these recommendations, patients can reduce their risk of further complications and improve their overall health outcomes.
-
This question is part of the following fields:
- Cardiovascular
-
00
Correct
00
Incorrect
00
:
00
:
00
Session Time
00
:
00
Average Question Time (
Secs)